Results 11 to 20 of about 23,898 (157)
Drugs in Context, 2013 Three therapeutic alternatives for prevention of stroke in patients with atrial fibrillation are available in dabigatran (an oral direct thrombin inhibitor), rivaroxaban, and apixaban (both oral blood coagulation factor Xa inhibitors).
James S Kalus
doaj +2 more sources
Antithrombotic Management in AF Patients Following Percutaneous Coronary Intervention: A European Perspective [PDF]
, 2023 AF is a highly prevalent disease, often requiring long-term oral anticoagulation to prevent stroke or systemic embolism. Coronary artery disease, which is common among AF patients, is often referred for myocardial revascularisation by percutaneous ...
Antonio Greco +3 more
core +1 more source
Marine Drugs, 2020 Thrombosis remains a prime reason of mortality worldwide. With the available antithrombotic drugs, bleeding remains the major downside of current treatments. This raises a clinical concern for all patients undergoing antithrombotic therapy. Novel antithrombotics from marine sources offer a promising therapeutic alternative to this pathology.
Rohini Dwivedi, Vitor H. Pomin
openaire +3 more sources
Antithrombotic dilemmas in stroke medicine: new data, unsolved challenges [PDF]
, 2022 Antithrombotic therapy is a key element of secondary prevention in patients who have had an ischaemic stroke or transient ischaemic attack. However, its use in clinical practice is not always straightforward.
Seiffge, David J +19 more
core +2 more sources
Vnitřní lékařství, 2018 Over the last 10 years some new drugs affecting blood clotting - antithrombotics - were invented. For more than half a century only warfarin and heparin were available. A better understanding of the pathways involved in activation of blood clotting, the links between these systems, and the impact of thrombosis on inflammation, have led to ...
Miloslava, Matýšková +2 more
openaire +2 more sources
Multidisciplinary approach to safety of antithrombotic therapy: focus on the gastrointestinal tract
, 2021 Multidisciplinary approach to safety of antithrombotic therapy used in clinical practice is reported. Such complications of antithrombotic therapy as gastrointestinal tract (GIT) erosion/ulceration and gastrointestinal bleeding are discussed in detail ...
Marina V. Buyanova +2 more
core +1 more source
P2Y12 Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease
JACC: Basic to Translational Science, 2017 Shunt thrombosis remains a major cause of morbidity and mortality, especially during the initial palliation for single-ventricle physiology. The authors present evidence that the P2Y12 inhibitor cangrelor may fill a therapeutic void in thromboprophylaxis.
Elisabeth A. Kaza, MD +10 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2019 Transcatheter interventions enable safe and efficient treatment of various structural heart diseases. However, therapy does not finished with the end of the procedure. Device thrombosis is a possible serious complication.
Anna Olasinska-Wisniewska, Marek Grygier
doaj +1 more source
Saponins: Research Progress and Their Potential Role in the Post-COVID-19 Pandemic Era
Pharmaceutics, 2023 In the post-COVID-19 pandemic era, the new global situation and the limited therapeutic management of the disease make it necessary to take urgent measures in more effective therapies and drug development in order to counteract the negative global ...
Daniel Mieres-Castro +1 more
doaj +1 more source
Scientifica, 2012 Patients with pulmonary embolism (PE) can be stratified into two different prognostic categories, based on the presence or absence of shock or sustained arterial hypotension.
Alessandro Squizzato
doaj +1 more source